Filter
890
Text search:
assays
Featured
Recommendations
131
New Publications
203
Language
Document type
No document type
433
Guidelines
224
Studies & Reports
116
Manuals
51
Fact sheets
29
Strategic & Response Plan
22
Training Material
7
Situation Updates
5
Resource Platforms
2
Online Courses
1
Countries / Regions
India
49
Global
33
Western and Central Europe
29
Germany
17
Latin America and the Carribbean
16
Eastern Europe
16
Tanzania
14
South Africa
14
Africa
14
Kenya
13
Russia
12
Uganda
11
Sierra Leone
10
Nigeria
10
Liberia
9
Brazil
9
Ukraine
9
East and Southern Africa
9
West and Central Africa
9
Ethiopia
8
Malawi
8
Mozambique
8
Bangladesh
7
Namibia
7
Middle East and North Africa
7
Nepal
5
Zambia
5
Cambodia
5
Colombia
5
Angola
5
Syria
4
Argentina
4
South–East Asia Region
4
Burkina Faso
3
Senegal
3
Congo, Democratic Republic of
3
USA
3
Cameroon
3
Ghana
3
Philippines
3
Rwanda
3
Sudan
3
Peru
3
Lesotho
3
Myanmar / Burma
3
Chile
3
Yemen
3
Asia
3
Venezuela
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Niger
2
Zimbabwe
2
Somalia
2
Pakistan
2
Iraq
2
Jordan
2
Afghanistan
2
Lebanon
2
Egypt
2
Chad
2
Indonesia
2
El Salvador
2
Libya
2
Madagascar
2
Eastern Europe and Central Asia
2
Qatar
2
Guinea
1
Guinea-Bissau
1
Morocco
1
Haiti
1
Turkey
1
China
1
Mauritania
1
Benin
1
Dominican Republic
1
Eswatini/ Swaziland
1
Switzerland
1
Cuba
1
Honduras
1
Ecuador
1
Bolivia
1
Guatemala
1
Mexico
1
Nicaragua
1
Sri Lanka
1
Western Pacific Region
1
Bhutan
1
Palestine
1
Djibouti
1
Mongolia
1
Congo-Brazzaville
1
Tajikistan
1
Estonia
1
Romania
1
Moldova
1
Iran
1
Kazakhstan
1
Georgia
1
North America
1
Jamaica
1
France
1
Tunisia
1
Portugal
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
243
Clinical Guidelines
141
Pharmacy & Technologies
47
Public Health
34
Key Resources
16
Women & Child Health
12
Capacity Building
3
Toolboxes
TB
176
COVID-19
125
HIV
116
NTDs
75
Rapid Response
30
Ebola & Marburg
24
Zika
23
AMR
23
Malaria
19
Pharmacy
15
Refugee
14
2.0 Rapid Response
13
Polio
10
NCDs
10
Planetary Health
8
Conflict
5
Mental Health
5
Specific Hazards
5
Caregiver
3
Natural Hazards
2
Cholera
1
Global Health Education
1
Health Financing Toolbox
1
NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME
Scientific Brief, 17 June 2020
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover
...
Tuberculosis (TB) is among the top ten most common causes of death globally and as a single infectious disease it top among infectious diseases. Furthermore, it is noted as the top causes of death among people infected with the human immunodeficiency virus (HIV). Despite recent decreases in the numb
...
Namibia is estimated to be at 94-97-93 as defined by the UNAIDS 95-95-95 treatment cascade, one of the first high burden countries to approach epidemic control. COP22 is about sustaining the impact of years of investment and partnership with the Namibian government and other stakeholders by employin
...
Relapsing malaria caused by Plasmodium vivax parasites poses a significant challenge to global malaria elimination efforts. About one third of the population remains at risk of contracting P. vivax malaria, and 85% of P. vivax infections stem from reactivated latent parasites, leading to chronic ana
...
WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries, molecular tools are vital for tracking resistance.
...
Meeting report, Kampala, Uganda,
7–8 November 2023
The purpose of this guide is to provide updated clinical guidance on TB/HIV, with an emphasis on diagnostic aspects—including new techniques—as well as current treatment, while maintaining a public health approach. By compiling and consolidating the latest World Health Organization recommendatio
...
2nd edition. The purpose of this document is to present updated standardized protocols that P. falciparum-endemic countries can use to determine the prevalence of parasites with pfhrp2/3 gene deletions causing negative HRP2 RDT results among symptomatic falciparum patients. The findings should be us
...
Preferred product characteristics and clinical development considerations
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN
...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B